The FDA reviewed T2Candida through its de novo classification process for certain novel low-to-moderate-risk medical devices. In a clinical study, T2Candida demonstrated a sensitivity of 91.1% and ...

Nosocomial candidaemia is associated with high mortality rates in critically ill paediatric patients; thus, the early detection and identification of the infectious agent is crucial for successful ...

Diagnosing a dangerous infection by a fungal yeast that often devastates hospital patients is now faster and more efficient. The new blood test has the potential to improve patient outcomes, as the ...

An experimental test could help doctors catch a deadly type of fungal infection in the blood within a few hours, rather than the few days it currently takes, a new study suggests. The test, which is ...

An antifungal drug demonstrated early signs of effectiveness in human testing, San Diego biotech Amplyx Pharmaceuticals said Monday. Privately held Amplyx also said it has acquired rights to another ...

Drug-resistant Candida auris can withstand most disinfectants and can remain within a person's body for weeks, experts say.

Thrush is one of the most common infections in the world. It's caused by the fungi Candida—specifically, the yeast Candida albicans. Although yeast infections are normally treated easily with ...

The drug-resistant superbug fungus Candida auris is spreading rapidly across the US, infecting at least 7,000 people in 27 ...

A new, rapid test for Candida infections of the bloodstream may cut mortality from 40% to 11%, according to a report published in the April 24 issue of Science Translational Medicine. Lori A. Neely, ...

A study by a team of clinicians and scientists from Manchester University NHS Foundation Trust and The University of Manchester, published in the latest issue of the Journal of Antimicrobial ...